A randomised clinical trial investigating the effect of indapamide versus placebo in
| Studied treatment | indapamide 2.5 mg/d |
| Control treatment | placebo |
| Female (%) | 28% |
| Age | 60 y |
| Patients | |
| Group sizes | 2841 / 2841 |
| Inclusion criteria | men and women with history of TIA or stroke not severely disabled, irrespective of their blood pressure |
| Exclusion criteria | neoplasm, rheumatic valvular disease, congestive cardiomyopathy, atrial fibrillation, secondary hypertension, hyperthyroidism, renal and hepatic disease, haemorrhagic disease, insulin dependent diabetes |
| Inclusion SBP | nil |
| Inclusion DBP | nil |
| Number of selection measures | |
| prior cardiovascular disease | |
| prior stroke | |
| heart failure | |
| Diabetes (%) | |
| prior myocardial infarction (%) |
| Blindness | Double blind | Inclusion period | |
| Follow-up duration | 2y | Centers | |
| Lost to FU | ND | geographical localisation | China |
| Primary endpoint | Design | Parallel groups | |
| ArretTrt1 | ND | ||
| Hypothese | Superiority | ||
| baseline BP | 154/93 (80-280/50-150) | ||
| Isolated systolic hypertension |
Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J (Engl) 1995;108:710-7 [PMID: 8575241] link to pdf add to Mendeley
Appears in following systematic reviews:
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
